Eastern diet takes on hypertension: can a 3-Month meal plan lower blood pressure?
NCT ID NCT07735091
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This trial tests whether a 3-month dietary program, called the Eastern Blood Pressure-Lowering Diet, can improve blood pressure in Chinese adults with hypertension. About 800 participants from workplace canteens will either receive standard hypertension care or also get specially designed lunches, low-sodium salt, and app-based support. The main goal is to see if the diet reduces resting systolic and diastolic blood pressure compared to standard care alone.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a culturally adapted blood pressure-lowering dietary pattern called the Eastern Blood Pressure-Lowering Diet, including specially designed weekday lunches, low-sodium salt, reduced-sodium seasonings, and app-based support
- What this could lead to
- If effective, this diet could offer a practical, non-drug approach to managing hypertension in Chinese adults, potentially reducing the need for medication.
- What could go wrong
- This is a single trial in a specific workplace setting, so results may not apply to other populations. The diet requires significant lifestyle changes, and long-term adherence may be challenging.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 800 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Nov 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged 18 to 60 years. * Employed by Shengli Oilfield and regularly receiving meals from a participating workplace canteen. * Regularly eats at the participating canteen, generally on at least 4 working days per week. * Diagnosed with primary hypertension by a qualified medical institution, or meets the diagnostic criterion of systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg on 3 measurements obtained on different days. * Hypertension is clinically stable. * Antihypertensive medication regimen is stable, when applicable. * Able and willing to comply with the dietary intervention, study assessments, and follow-up procedures. * Provides written informed consent voluntarily. Exclusion Criteria: * Secondary hypertension. * Pregnancy, breastfeeding, or planning to become pregnant during the study period. * Serious food allergy or intolerance to major foods included in the intervention diet, such as nuts, dairy products, or gluten-containing foods. * Major cardiovascular or cerebrovascular event within the previous 6 months, such as myocardial infarction or stroke. * Severe cardiopulmonary disease, such as heart failure or severe asthma. * Cancer, advanced kidney disease, severe liver disease, or another serious medical condition. * A medical condition requiring a specialized therapeutic diet that would interfere with the study intervention. * Severe psychiatric illness. * Severe cognitive impairment that prevents understanding of the informed consent form or compliance with study procedures. * Hearing impairment or physical disability that would substantially interfere with participation. * Any other condition that, in the judgment of the research team, makes the individual unsuitable for participation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypertension are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sinopec Shengli Petroleum Administrative Bureau Co., Ltd.
Dongying, Shandong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Inflatable leg cuffs tested as a Two-for-One therapy for high blood pressure and erectile dysfunction
- Can nurses and home monitors tame high blood pressure?
- Can pressing six points on the body help older adults sleep?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Could a quieter, automated blood pressure check help more people control hypertension?
- Can a phone call boost confidence in managing high blood pressure?